Skip to main content
Premium Trial:

Request an Annual Quote

Harvard Bioscience Posts Increased Revenues, Income for Q4

NEW YORK, March 3 (GenomeWeb News) - Harvard Bioscience yesterday reported increased revenues and earnings for the last quarter of 2003.


Revenues increased to $24.2 million, up from $18.9 million during the same period in 2002.


R&D expenses were $1.6 million, up from $1.1 million for the year-ago period.


Harvard Bioscience's net income for the quarter was $1.8 million, or $.06 per share, up from a net loss of $1 million, or $.03 per share, during the last quarter of 2002.


As of Dec. 31, the company had $8.2 million in cash and cash equivalents.


Harvard Bioscience also said it has closed down its Genomic Solutions sales office in Japan this year, using its current distributor instead. The company acquired Genomic Solutions in 2002.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.